A Randomised Phase II Study of Interleukin-1 Receptor Antagonist in Acute Stroke Patients

Journal of Neurology, Neurosurgery and Psychiatry - United Kingdom
doi 10.1136/jnnp.2004.054882
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Interleukin-1, Interleukin-1 Receptor, and Interleukin-1 Receptor Antagonist

Proceedings of the Nutrition Society
MedicineNutritionDietetics
1994English

Interleukin-1 Receptor Antagonist in Animal Models of Stroke: A Fair Summing Up?

Journal of Stroke and Cerebrovascular Diseases
SurgeryNeurologyCardiovascular MedicineRehabilitationCardiology
2010English

Increased Fibrinogen Synthesis in Mice During the Acute Phase Response: Co-Operative Interaction of Interleukin 1, Interleukin 6, and Interleukin 1 Receptor Antagonist

1993English

Phase 1 Study of the MDM2 Antagonist RO6839921 in Patients With Acute Myeloid Leukemia

Investigational New Drugs
OncologyPharmacology
2020English

Deficiency of Interleukin-1 Receptor Antagonist Responsive to Anakinra

Pediatric Dermatology
DermatologyChild HealthPediatricsPerinatology
2012English

Anti-Inflammatory Properties of a Novel Peptide Interleukin 1 Receptor Antagonist

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2014English

Interleukin-1 and Interleukin-1 Receptor Antagonist Gene Polymorphisms and Gastric Cancer: A Meta-Analysis

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2006English

Structure Studies of Recombinant Interleukin-1 Receptor Antagonist Protein

Acta Crystallographica Section A Foundations of Crystallography
1993English

Multiple Sclerosis: Longitudinal Measurement of Interleukin-1 Receptor Antagonist.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy